GlassScriptPhysician profile
Sumeet Jindal
NPI 1023540010
$4,680.69
in general payments reported to CMS, 2019-2025
15 companies · $1,663 in 2025
The $1,663 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,592 · 2020: $40.79 · 2022: $784 · 2023: $311 · 2024: $289 · 2025: $1,663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $763.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,820.14 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,569.42 | 2019 | |
| Alcon Vision LLC | $862.02 | 2019-2025 | Hydrus Microstent, Clareon, Argos |
| Merz North America, INC. | $127.39 | 2024 | |
| Rayner Intraocular Lenses Limited | $87.51 | 2024 | Rayone Spheric, Rayone Aspheric, Omidria |
| Abbvie INC. | $45.55 | 2022-2025 | |
| Revance Therapeutics, INC. | $35.45 | 2024 | Daxxify |
| Glaukos Corporation | $19.49 | 2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Conmed Corporation | $17.70 | 2023 | Visiclear |
| Biotissue Holdings INC. | $17.35 | 2025 | |
| Bausch & Lomb Americas INC. | $17.16 | 2025 | Envista Envy Iol |
| Lkc Technologies, INC. | $16.60 | 2022 | |
| New World Medical,INC. | $16.42 | 2022 | |
| Baxter Healthcare | $15.48 | 2023 | Artiss |
| Takeda Pharmaceuticals U.S.A., INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumeet Jindal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.